Subscribe / Renew
|► Subscribe to our Free Weekly Newsletter|
December 1, 2020
Moderna Inc. said Monday it was asking U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — intensifying the race to begin limited vaccinations as the coronavirus rampage worsens.
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago in China, the virus has killed more than 1.4 million people worldwide.
. . .